Amneal Pharmaceuticals, Inc. (AMRX)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Affordable Medicines Net Revenue	1.81B	1.75B	1.69B
Specialty Net Revenue	574.73M	528.51M	445.75M
AvKARE Net Revenue	732.28M	744.73M	662.95M
Revenue (Total)	3.12B	3.02B	2.79B

Gross Profit

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Affordable Medicines Gross Profit	729.09M	683.92M	673.90M
Specialty Gross Profit	346.41M	282.59M	242.93M
AvKARE Gross Profit	150.29M	146.79M	103.61M
Gross Profit (Total)	1.23B	1.11B	1.02B

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Affordable Medicines Operating Income	411.65M	380.80M	270.10M
Specialty Operating Income	170.44M	116.00M	113.58M
AvKARE Operating Income	84.29M	83.62M	42.90M
Corporate and Other Operating Income	-212.46M	-186.32M	-177.26M
Operating Income (Total)	453.92M	394.10M	249.33M

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 27, 2026

Data Sources Report a data error